V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20209923 | 20078181 | 1.74 | 67 | Palliative (P) | 2019-12-09 | 2019-12-21 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101357842 |
| 20209928 | 20078182 | null | 89.1 | Palliative (P) | 2017-07-08 | 2017-07-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100982535 |
| 20209930 | 20078183 | 1.78 | 60.8 | Palliative (P) | null | 2018-02-07 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101592159 |
| 20209931 | 20078184 | 1.63 | 71.8 | 03 | 2018-02-22 | 2018-03-10 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101398989 |
| 20209936 | 20078185 | 1.58 | 52.9 | Palliative (P) | 2019-10-07 | 2019-10-17 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101316285 |
| 20209940 | 20078186 | 1.81 | 68.1 | Curative (C) | 2016-06-24 | 2016-06-24 | Capecitabine (21days) + Carboplatin | 02 | Y | DOXORUBICIN EMBOLISATION | 101050534 |
| 20209948 | 20078187 | 1.74 | 83 | Palliative (P) | 2018-04-14 | 2018-04-21 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101727852 |
| 20209950 | 20078188 | 1.66 | 60.4 | Neo-adjuvant (N) | 2018-07-21 | 2018-07-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101468199 |
| 20209956 | 20078189 | 1.84 | 135 | Neo-adjuvant (N) | 2018-12-03 | 2018-12-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100555382 |
| 20209958 | 20078190 | 0 | 0 | null | null | 2018-12-15 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100118904 |
| 20209961 | 20078191 | 1.75 | 60.25 | Adjuvant (A) | 2018-11-23 | 2018-12-14 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101128981 |
| 20209964 | 20078192 | 1.68 | 45 | null | 2021-07-14 | 2021-07-19 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101855877 |
| 20209968 | 20078193 | 1.5 | 60 | null | 2019-12-21 | 2019-12-21 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100693326 |
| 20209969 | 20078194 | 1.61 | 82.4 | null | 2018-04-01 | 2018-04-16 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101714266 |
| 20209970 | 20078195 | 1.64 | 61.6 | Palliative (P) | 2016-09-25 | 2016-09-25 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100061836 |
| 20209976 | 20078196 | 1.58 | 79.2 | Palliative (P) | 2016-04-25 | 2016-04-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101478966 |
| 20209980 | 20078197 | 1.73 | 80 | Curative (C) | 2018-09-16 | 2018-10-17 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 100661173 |
| 20209983 | 20078198 | 1.5 | 68.95 | Curative (C) | 2017-08-07 | 2017-08-09 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 100007128 |
| 20209987 | 20078199 | 0 | 0 | Curative (C) | 2019-07-01 | 2019-07-18 | Doxorubicin chemoembolisation | N | Y | DOXORUBICIN EMBOLISATION | 101098751 |
| 20209990 | 20078200 | 1.81 | 49 | Neo-adjuvant (N) | 2018-09-04 | 2018-09-04 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 101455275 |
| 20209994 | 20078201 | 1.72 | 60.9 | Palliative (P) | 2018-12-05 | 2018-12-05 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101828640 |
| 20209998 | 20078202 | 1.78 | 82.6 | null | 2016-11-16 | 2016-11-30 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100049219 |
| 20210003 | 20078203 | null | 62.5 | Neo-adjuvant (N) | 2019-08-21 | 2019-09-17 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101852456 |
| 20210007 | 20078204 | 1.59 | 63.9 | Neo-adjuvant (N) | null | 2021-01-13 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100314510 |
| 20210010 | 20078205 | 1.78 | 68.65 | Palliative (P) | 2020-02-18 | 2020-03-30 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100808742 |
| 20210021 | 20078206 | 0 | 0 | Adjuvant (A) | 2018-02-11 | 2018-02-27 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100964593 |
| 20210024 | 20078207 | 1.68 | null | Curative (C) | 2019-11-17 | 2019-11-20 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101677655 |
| 20210029 | 20078208 | 1.73 | 66.8 | Palliative (P) | 2019-05-06 | 2019-05-25 | CISPLATIN + FLUOROURACIL | 2 | null | CISPLATIN + FLUOROURACIL | 101636630 |
| 20210035 | 20078209 | 1.71 | 73 | Neo-adjuvant (N) | 2016-08-13 | 2016-08-17 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101299151 |
| 20210036 | 20078210 | 1.72 | 79.95 | Palliative (P) | null | 2017-06-10 | CAPECITABINE + CARBOPLATIN | 2 | N | CAPECITABINE + CARBOPLATIN | 100131605 |
| 20210038 | 20078211 | 0 | 0 | Curative (C) | 2017-09-25 | 2017-10-23 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101620950 |
| 20210043 | 20078212 | 1.77 | 81.2 | Palliative (P) | 2018-03-09 | 2018-03-17 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101047499 |
| 20210046 | 20078213 | 0 | 0 | Palliative (P) | null | 2018-04-30 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100929952 |
| 20210050 | 20078214 | 1.7 | 57 | Curative (C) | 2019-09-29 | 2019-10-10 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101646801 |
| 20210054 | 20078215 | 1.69 | 51 | Neo-adjuvant (N) | 2017-08-29 | 2017-09-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100245730 |
| 20210058 | 20078216 | 1.7 | 91 | Neo-adjuvant (N) | 2017-02-28 | 2017-04-03 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101171870 |
| 20210064 | 20078217 | 1.63 | 90 | Palliative (P) | 2019-12-21 | 2019-12-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100590158 |
| 20210068 | 20078218 | 0 | 0 | Neo-adjuvant (N) | 2017-04-29 | 2017-05-23 | Doxorubicin chemoembolisation | null | null | DOXORUBICIN EMBOLISATION | 100292339 |
| 20210069 | 20078219 | 1.57 | 110.9 | Palliative (P) | 2017-03-10 | 2017-03-10 | CISPLATIN + FLUOROURACIL | null | Y | CISPLATIN + FLUOROURACIL | 100743656 |
| 20210078 | 20078220 | 1.75 | 97.9 | 03 | 2019-01-29 | 2019-02-20 | Capecitabine (21days) + Carboplatin | null | N | CISPLATIN + FLUOROURACIL | 100725976 |
| 20210080 | 20078221 | 1.69 | 75 | Palliative (P) | 2020-01-05 | 2020-01-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101084143 |
| 20210088 | 20078222 | null | null | Neo-adjuvant (N) | 2017-12-31 | 2018-01-29 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100556613 |
| 20210095 | 20078223 | 1.81 | 109 | Palliative (P) | 2018-12-23 | 2019-01-09 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100891355 |
| 20210098 | 20078224 | 1.73 | 71 | Curative (C) | 2019-05-28 | 2019-05-28 | Capecitabine (21days) + Carboplatin | 02 | Y | CISPLATIN + FLUOROURACIL | 101867901 |
| 20210102 | 20078225 | 1.66 | 60 | null | 2018-03-24 | 2018-04-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101689861 |
| 20210106 | 20078226 | 0 | 0 | Palliative (P) | 2016-11-14 | 2016-12-05 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100082573 |
| 20210107 | 20078227 | 1.48 | 46.9 | Palliative (P) | 2019-06-19 | 2019-07-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101260806 |
| 20210109 | 20078228 | 1.78 | 86.5 | Curative (C) | 2018-10-12 | 2018-10-24 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100055957 |
| 20210113 | 20078229 | 1.73 | 97.2 | Curative (C) | 2019-05-05 | 2019-06-09 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101820538 |
| 20210114 | 20078230 | 1.56 | 62.3 | 03 | 2016-10-08 | 2016-10-08 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101173437 |